ANI PHARMACEUTICALS INC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 528,276 | $35,368,078 | 0.10% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 9, 2025 |
| June 30, 2025 | 490,536 | $32,007,474 | 0.08% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 29, 2025 |
| Sept. 30, 2025 | 348,680 | $31,939,088 | 0.08% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 316,693 | $24,999,745 | 0.07% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 9, 2026 |
| March 31, 2026 | 327,276 | $25,167,524 | 0.08% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 8, 2026 |
| June 30, 2026 | 258,173 | $21,371,561 | 0.06% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.